7 months ago
BPL Medical Technologies Unveils AI and Imaging Innovations at IRIA 2026
BPL Medical Technologies showed off new imaging and AI tools at a big conference in Hyderabad.
They bought a company in South Korea to help them do this.
They also introduced a new AI tool called BPL Cortex to help doctors make better decisions.
They partnered with another company to make this tool even better.
They also had a robot that helped with teaching sessions about imaging and AI.
The company wants to make sure these tools are useful and affordable for India's healthcare system.
BPL Medical Technologies showcased advanced imaging and AI capabilities at IRIA 2026 in Hyderabad.
The company acquired Yozma BMTech Co., Ltd. in South Korea in December 2025 to expand its global imaging and diagnostics capabilities.
BPL launched BPL Cortex, an AI-powered radiology platform, and partnered with 5C Network to develop an OEM-embedded solution.
The company focused on women's health imaging, including advancements in bone densitometry and mammography.
RIA, a robotic assistant, hosted educational sessions on imaging solutions, women's health, and AI in radiology.
- Who
- BPL Medical Technologies
- What
- Unveiled advanced imaging and AI capabilities at IRIA 2026
- Where
- Hyderabad, India
- When
- December 2025 (acquisition), 2026 (event)
- Why
- To showcase next-generation imaging and digital health solutions, and expand global imaging and diagnostics capabilities
Key facts
- Event
- IRIA 2026, Hyderabad
- Company
- BPL Medical Technologies
- Acquisition
- Yozma BMTech Co., Ltd. (South Korea, December 2025)
- New Product
- BPL Cortex (AI-powered radiology platform)
- Partnership
- 5C Network (AI-native radiology platform)
- Robotic Assistant
- RIA
- Focus Areas
- Precision imaging, women's health, AI in radiology
Quotes
Dr. Shravan
Managing Director, BPL Medical Technologies
“IRIA provides a valuable platform to engage directly with the radiology community. Our focus remains on building integrated imaging and AI solutions that enhance diagnostic confidence while remaining scalable, affordable, and relevant to India’s healthcare ecosystem.”
theprint.in




